SlideShare a Scribd company logo
11--ANEMIA INANEMIA IN
PEDIATRICSPEDIATRICS
for clinical pharmacyfor clinical pharmacy
Prof Dr Hussein AbdeldayemProf Dr Hussein Abdeldayem
Professor of Pediatrics,Professor of Pediatrics,
Alex UniversityAlex University
FACTORS FORFACTORS FOR
ERYTHROPOIESISERYTHROPOIESIS
 Bone MarrowBone Marrow
 ERYTHROPOIETIN (90%kidney,ERYTHROPOIETIN (90%kidney,
10%liver)10%liver)
 Nutritional factors:Nutritional factors:
1- protein: AA1- protein: AA
2- iron2- iron
3- B12, folic acid3- B12, folic acid
4- copper, cobalt4- copper, cobalt
5- ascorbic acid5- ascorbic acid
Regulation ofRegulation of
ErythropoiesisErythropoiesis
 While the kidney produces most of theWhile the kidney produces most of the
erythropoietin, the liver and othererythropoietin, the liver and other
tissues also produce some.tissues also produce some.
 In fetal life, the liver produced all of theIn fetal life, the liver produced all of the
erythropoietinerythropoietin –– as the final kidneyas the final kidney ––
the metanephros - had not yetthe metanephros - had not yet
completed development.completed development.
Regulation ofRegulation of
ErythropoiesisErythropoiesis
 How many are produced:How many are produced:
– 25 billion /24 hours.25 billion /24 hours.
– The entering cells are reticulocytes whichThe entering cells are reticulocytes which
should be 1% of the total population ofshould be 1% of the total population of
circulating erythrocytes.circulating erythrocytes.
– Erythrocytes last 120 days and areErythrocytes last 120 days and are
destroyed by the spleen.destroyed by the spleen.
– Red cell production should equal red cellRed cell production should equal red cell
destruction.destruction.
Uses of erythropoietinUses of erythropoietin
epoetin alfaepoetin alfa
Indication:
 Anemia of chronic renal failure.
 Cancer and AIDS chemotherapy
 Transplant patients
 Chronic inflammatrory illness as SLE
 Prematurity .
 Anemia in surgical or extracorporeal proceduresAnemia in surgical or extracorporeal procedures
because the pumps may have destroyed many redbecause the pumps may have destroyed many red
blood cells.blood cells.
Uses of epoetin alfaUses of epoetin alfa
 Recommended starting dose is 80 – 120 U/kg -
sc three times a week. Average maintenance
dose - 75 U/kg, three times a week in most
patients.
 The most common side effect - aggravation of
hypertension
Normal CBC
Bone Marrow
Hematopoiesis
Hematologic Value
Hb (g/dl)
Ht %
RBCs
Nucleated RBCs %
Reticulocytes %
Cord
17
55
5.3
6
5
3 m
11.5
35
4.3
0
1
6m-6y
12.5
37
4.7
0
1
7-12 y
13
39
5
0
1
Normal RBC
What is AnemiaWhat is Anemia??
 Anemia is a decrease in HbAnemia is a decrease in Hb
concentration or the number of redconcentration or the number of red
blood cells (RBC) as measuredblood cells (RBC) as measured
– 1. gm per cu mm or1. gm per cu mm or
– 2. by volume of packed RBC per 100 ml2. by volume of packed RBC per 100 ml
of blood. This is clinically obtained byof blood. This is clinically obtained by
doing a hematocrit (HCT)doing a hematocrit (HCT)
Below average of normal values for ageBelow average of normal values for age
and sexand sex
ANEMIAS
CLASSIFICATION OF ANEMIAS
1. Anemia from inadequate erythropoiesis.
2. Anemia of blood loss (post-hemorrhagic).
3. Anemia due to ↑ destruction (hemolytic).
ANEMIAS
Diagnosis:
Type, Severity, Etiology
CLINICAL EVALUATION:
1. Common manifestations: Pallor, exercise
intolerance, dyspnoea, palpitations, headache, lack of
conc., irritability, syncope, hemic murmurs.
2. Less commonly: anorexia, nausea, flatulence,
constipation, mild proteinuria, fever
3. Severe cases: ↑ C.O, CHF
PallorPallor
ANEMIA IN PEDIATRICS 2019
Laboratory Investigations
1. CBC
* Hct, Hb
* RBCs count, WBCs, Platelets
* Reticulocytes
•Cell morphology
•* Blood Indices:
MCV MCH MCHC
RDW=11.5-14.5%
Primary LaboratoryPrimary Laboratory
InvestigationInvestigation
 The increased reticulocyte count isThe increased reticulocyte count is
usually accompanied by peripheralusually accompanied by peripheral
smear RBC polychromasiasmear RBC polychromasia
Reticulocyte CountReticulocyte Count
 Is required in the evaluationIs required in the evaluation
of all patients with anemia asof all patients with anemia as
it is a simple measure ofit is a simple measure of
productionproduction
 Young RBC that still containsYoung RBC that still contains
a small amount of RNAa small amount of RNA
 Normally take 1 day forNormally take 1 day for
reticulocyte to mature.reticulocyte to mature.
 1/1201/120thth
of RBC normallyof RBC normally
Classification according to MCV
Microcytic
Iron deficiency
Thalassemia
Lead poisoning
Chronic disease
Normocytic
↓ Production
Macrocytic
Vit. B12
Folic acid
2. Biochemical Investigations
A. Iron status
Serum iron (N 60-150 µg/dl)
TIBC (N 100-400 µg/dl)
Serum ferritin (N 10-150 ng/dl)
B. Megaloblastic anemia
Serum vit. B12, folate
Laboratory Investigations
Commonest Causes of Anemia
Nutritional Deficiency : Iron Deficiency
Acute Hemolytic: G6PDD
Chronic Hemolytic: β-Thalassemia
ANEMIA IN PEDIATRICS 2019
Iron deficiency Anemia
ANEMIAS DUE TO DEFICIENCYANEMIAS DUE TO DEFICIENCY
OF SPECIFIC NUTRIENTSOF SPECIFIC NUTRIENTS
IRON DEFICIENCY ANEMIAIRON DEFICIENCY ANEMIA
 Most commonMost common nutritional deficiency innutritional deficiency in
children and is worldwide.children and is worldwide.
 Highest :Highest : ●● 6 - 246 - 24 monthsmonths
●● artificially fed infants.artificially fed infants.
●● low socioeconomic status.low socioeconomic status.
Iron-deficiency anemia remains the mostIron-deficiency anemia remains the most
common nutritional problem from a globalcommon nutritional problem from a global
perspective, it is estimated that roughly 2-5%perspective, it is estimated that roughly 2-5%
of the world population are anaemic.of the world population are anaemic.
Prevalence of Iron Deficiency AnemiaPrevalence of Iron Deficiency Anemia
Normal Daily IronNormal Daily Iron
RequirementsRequirements
 FT baby: with store enough for 4 moFT baby: with store enough for 4 mo
 PMT baby: with store enough for 2 moPMT baby: with store enough for 2 mo
 1mg/kg/day elemental iron for infants and1mg/kg/day elemental iron for infants and
children (max 15 mg/day)children (max 15 mg/day)
 2 mg/kg/day elemental iron for low birth2 mg/kg/day elemental iron for low birth
weight and newborns with very low initial Hbweight and newborns with very low initial Hb
valuesvalues
 6 mg/kg/day elemental iron is needed for tt6 mg/kg/day elemental iron is needed for tt
for 3 mofor 3 mo
Dietary ironDietary iron
 I:Heme iron compoundsI:Heme iron compounds (hemoglobin and(hemoglobin and
myoglobin) :myoglobin) : foods of animal origin:foods of animal origin: 1.5 - 6 mg1.5 - 6 mg
iron /100 giron /100 g meat, liver, poultry, fish, etc.meat, liver, poultry, fish, etc.
Easily digested and readily absorbed.Easily digested and readily absorbed.
Absorption is not affected by diet.Absorption is not affected by diet.
 II:Non-heme ironII:Non-heme iron ( ferric iron salts ) :( ferric iron salts ) :
egg yolk, green vegetables, whole grains, legumes,egg yolk, green vegetables, whole grains, legumes,
nutsnuts (( ++ 1.5 mg/100 g)1.5 mg/100 g). ferric. ferric →→ ferrous beforeferrous before
absorption.absorption.
Absorption (50% : breast milk , 10% of cowAbsorption (50% : breast milk , 10% of cow ’’s milks milk
iron .iron .
AbsorptionAbsorption ↑↑ : Vitamin C, sugar, amino acids (meat,: Vitamin C, sugar, amino acids (meat,
poultry, fish) & HCl.poultry, fish) & HCl.
AbsorptionAbsorption ↓↓ : Fibers (bran), tannate (tea),: Fibers (bran), tannate (tea),
Iron is used inIron is used in::
 Hemoglobin: transfer O2 to tissuesHemoglobin: transfer O2 to tissues
 Heme enzymes, e.g., cytochromes, catalase,Heme enzymes, e.g., cytochromes, catalase,
peroxidaseperoxidase
 Myoglobin:transfer O2 to muscle cellsMyoglobin:transfer O2 to muscle cells
 Metalloflavoprotein enzymes such as xanthineMetalloflavoprotein enzymes such as xanthine
oxidaseoxidase
 The mitochondrial enzyme alpha-The mitochondrial enzyme alpha-
glycerophosphate oxidase and otherglycerophosphate oxidase and other
mitochondrial enzymes.mitochondrial enzymes.
 Other enzymes and processesOther enzymes and processes
 Most commonMost common nutritional deficiency innutritional deficiency in
children and is worldwide.children and is worldwide.
 More common at:More common at:
●● 6 - 246 - 24 monthsmonths
●● artificially fed infants.artificially fed infants.
●● low socioeconomic statuslow socioeconomic status
IRON DEFICIENCYIRON DEFICIENCY
ANEMIAANEMIA
STAGESSTAGES
Iron stores S.IronIron stores S.Iron
AnemiaAnemia
(s. ferritin)(s. ferritin)
 Stage of IRONStage of IRON Low Normal NoneLow Normal None
DEPLETIONDEPLETION
 Stage of IRONStage of IRON Absent Low NoneAbsent Low None
DEFICIENCYDEFICIENCY
 Stage of IRONStage of IRON Absent Low PresentAbsent Low Present
DEF. ANEMIADEF. ANEMIA
 ↓↓ iron stores.iron stores.
 ↓↓ iron‑storage protein (ferritin)iron‑storage protein (ferritin)
 ↓↓ serum ironserum iron
 ↑↑iron binding capacity TIBC.iron binding capacity TIBC.
 Anemia: hypochromia,microcytosis.Anemia: hypochromia,microcytosis.
 ↓↓ activity of iron‑containing intraactivity of iron‑containing intra ­­
cellular enzymes (e.g. CNS -MAO).cellular enzymes (e.g. CNS -MAO).
PathogenesisPathogenesis
Clinical manifestationsClinical manifestations
- Particular CP due to effect of iron def. on- Particular CP due to effect of iron def. on
systems:systems:
 GIT:GIT: Anorexia, glossitis, Pica (ingestion of wallAnorexia, glossitis, Pica (ingestion of wall
plaster, clay), Geophagia (earth), Pagophagiaplaster, clay), Geophagia (earth), Pagophagia
(ice,(ice,
 CNS:CNS: Short attention span, irritability, breathShort attention span, irritability, breath
holding,holding,
↓↓ alertness, ↓ learning ability and schoolalertness, ↓ learning ability and school
performance.performance.
 IRON replacement TREATMENT (oral,IRON replacement TREATMENT (oral,
IM, IV)IM, IV)
 TREAT THE CAUSETREAT THE CAUSE
TREATMENTTREATMENT
TreatmentTreatment
Oral Iron saltsOral Iron salts::
6 mg/kg/day elemental for 3 mo6 mg/kg/day elemental for 3 mo
 Ferrous sulfate drops for infants ( 20%Ferrous sulfate drops for infants ( 20%
elemental iron).elemental iron).
 Ferrous gluconate drops ( 12 % elementalFerrous gluconate drops ( 12 % elemental
iron).iron).
 ferrous fumarate (30% elemental iron) tabletsferrous fumarate (30% elemental iron) tablets
or syrup for older children.or syrup for older children.
 Iron better between meals. fibers (e.g. wholeIron better between meals. fibers (e.g. whole
bread and cereals), tannate (like tea),bread and cereals), tannate (like tea),
phosphates (in bread, cow's milk and eggphosphates (in bread, cow's milk and egg
yolk) and phytic acid ↓ absorption of iron.yolk) and phytic acid ↓ absorption of iron.
 absorption ↑ by vitamin C (e.g. citrous fruits),absorption ↑ by vitamin C (e.g. citrous fruits),
sugar and amino acids (meat, poultry, fish).sugar and amino acids (meat, poultry, fish).
TreatmentTreatment
Parenteral iron therapyParenteral iron therapy :: Iron dextranIron dextran
mixture (mixture (ImferonImferon))®®
50 mg elemental iron / ml50 mg elemental iron / ml
only in intolerance or malabsorptiononly in intolerance or malabsorption
Packed RBC transfusionPacked RBC transfusion :: SeverelySeverely
anemic children with Hb < 4 g/dlanemic children with Hb < 4 g/dl
Treatment of etiologyTreatment of etiology correct diet , ttcorrect diet , tt
parasiteparasite
 These preparation are mostlyThese preparation are mostly
available as ferrous(Fe+2) and someavailable as ferrous(Fe+2) and some
in ferric(Fe+3)formin ferric(Fe+3)form
  Ferrous salt are better absorbedFerrous salt are better absorbed
than ferric saltsthan ferric salts
ORAL IRON THERAPYORAL IRON THERAPY
 Iron is poorly absorbed in the form ofIron is poorly absorbed in the form of
carbonate, citrate and pyrophosphate,carbonate, citrate and pyrophosphate,
colloidal iron and iron carbohydratecolloidal iron and iron carbohydrate
complexcomplex
 FORMS :FORMS :
Tablets, capsulesTablets, capsules
Sugar coated & uncoated tablets •Sugar coated & uncoated tablets •
Slow release tabsSlow release tabs
chewable tabs •chewable tabs •
Drops &syrups—used by children'sDrops &syrups—used by children's
 1. Ferrous sulphate: 20 – 32% iron1. Ferrous sulphate: 20 – 32% iron
 2. Ferrous fumarate: 33% elemental2. Ferrous fumarate: 33% elemental
ironiron
 3. Ferrous gluconate : 12% elemental3. Ferrous gluconate : 12% elemental
ironiron
 4. Colloidal ferric hydroxide:50%4. Colloidal ferric hydroxide:50%
elemental iron •elemental iron •
 Other oral preparations are ferrousOther oral preparations are ferrous
choline citrate , ferric ammoniumcholine citrate , ferric ammonium
citrate , iron calcium complex, ironcitrate , iron calcium complex, iron
hydroxy polymatose.hydroxy polymatose.
FERRIC
HYDROCHLORIDE
POLYMALTOSE
 It is rapidly absorbed, with a high rate of ironIt is rapidly absorbed, with a high rate of iron
utilization and produces an effective increase inutilization and produces an effective increase in
Haemoglobin. Due to its favourable nonionicHaemoglobin. Due to its favourable nonionic
nature it has the following properties unlikenature it has the following properties unlike
ionised iron salt preparations: · Ferose does notionised iron salt preparations: · Ferose does not
give rise to irritation of the intestinal mucosa andgive rise to irritation of the intestinal mucosa and
does not stain the teeth. · Ferose has palatable,does not stain the teeth. · Ferose has palatable,
non metallic taste (Ferose chewable tablets havenon metallic taste (Ferose chewable tablets have
chocolate flavour and are acceptable even by thechocolate flavour and are acceptable even by the
most resistant patients of all ages). · Ferose hasmost resistant patients of all ages). · Ferose has
excellent tolerance.excellent tolerance.
Ferrous form of oral ironFerrous form of oral iron
FEROSEFEROSE
 •• Important points to remember ;ElementalImportant points to remember ;Elemental
iron content and not quantity of ironiron content and not quantity of iron
compound per unit dose to be consideredcompound per unit dose to be considered
 Sustained released preparations expensiveSustained released preparations expensive
and irrationaland irrational
 Liquid formulations: should be put on backLiquid formulations: should be put on back
of tongue and swallowedof tongue and swallowed
Iron saltsIron salts
 Ferrous sulfateFerrous sulfate ––least expensiveleast expensive –– treatment oftreatment of
choicechoice
 Ferrous salts (sulfate, fumarate, gluconate,Ferrous salts (sulfate, fumarate, gluconate,
succinate) are absorbed about three times assuccinate) are absorbed about three times as
well as ferric salts.well as ferric salts.
 Vitamin C increases absorption - AscorbicVitamin C increases absorption - Ascorbic
acid, 200 mg or more, increases absorption byacid, 200 mg or more, increases absorption by
at least 30% (with increased incidence of sideat least 30% (with increased incidence of side
effects too)effects too)
 Carbonyl iron: microspheres of pure ironCarbonyl iron: microspheres of pure iron –– lessless
gastrointestinal toxicity than iron saltsgastrointestinal toxicity than iron salts
 •• Constipation (BLACK) is commonConstipation (BLACK) is common
than diarrheathan diarrhea
 •• Epigastric painEpigastric pain
 •• VomitingVomiting
 •• Heart burnHeart burn
 •• Metallic tasteMetallic taste
 •• NauseaNausea
 •• Staining of teeth.Staining of teeth.
Adverse reactions to oralAdverse reactions to oral
ironiron
 •• Oral iron is not toleratedOral iron is not tolerated
 •• Failure to absorb oral ironFailure to absorb oral iron
 •• Non compliance to oral ironNon compliance to oral iron
 •• In presence of severe deficiency withIn presence of severe deficiency with
chronic bleedingchronic bleeding
Indications of parenteralIndications of parenteral
therapytherapy
 •• Parenteral iron therapy needsParenteral iron therapy needs
calculation of total iron requirement ofcalculation of total iron requirement of
the patient –the patient –
Iron requirement (mg) = 4.4 X Body wtIron requirement (mg) = 4.4 X Body wt
(Kg) X Hb deficit g/dL(Kg) X Hb deficit g/dL
Calculation for parenteralCalculation for parenteral
ironiron
 1. Iron dextran (Imferon): I.V/ I.M1. Iron dextran (Imferon): I.V/ I.M
 2. Iron sorbitol citric acid complex:2. Iron sorbitol citric acid complex:
Only I.M 3. Iron carbohydrate complexOnly I.M 3. Iron carbohydrate complex
: I.M: I.M
 4. Sodium ferric gluconate: Recently4. Sodium ferric gluconate: Recently
approved preparation for I.V use hasapproved preparation for I.V use has
much lower risk of anaphylacticmuch lower risk of anaphylactic
reaction than iron dextranreaction than iron dextran
Parenteral ironParenteral iron
preparationspreparations
 •• Iron dextran and iron sorbitol bothIron dextran and iron sorbitol both
contain 50 mg/mL recommended dosecontain 50 mg/mL recommended dose
is 100 mg daily 2 mL on alternate daysis 100 mg daily 2 mL on alternate days
until total required dose isuntil total required dose is
administered or maximum 2 g .administered or maximum 2 g .
 To prevent staining to skin given deepTo prevent staining to skin given deep
I.M in buttock using z track techniqueI.M in buttock using z track technique
I.M therapyI.M therapy
Elemental iron 100 mg (As Ferric
hydroxide polymaltose complex)
 •• Intramuscular: – Local pain at site ,Intramuscular: – Local pain at site ,
pigmentation of skin , sterile abcesspigmentation of skin , sterile abcess
 –– Systemic: headache, fever,Systemic: headache, fever,
arthralgia, backache, tachycardia,arthralgia, backache, tachycardia,
flushing hemolysis and collapse theseflushing hemolysis and collapse these
effects are probably due to excessiveeffects are probably due to excessive
amount of free iron in plasmaamount of free iron in plasma
 –– Iron sorbitol may causeIron sorbitol may cause
disorientation and temporary loss ofdisorientation and temporary loss of
taste, urine turns black on standingtaste, urine turns black on standing
Adverse effectsAdverse effects
 •• Iron dextran after test dose 0.5 mLIron dextran after test dose 0.5 mL
iron dextran injected I.V over 5 to 10iron dextran injected I.V over 5 to 10
minmin
 •• Total dose required diluted in 500 mLTotal dose required diluted in 500 mL
NS & infused slowly over 6 to 8 hoursNS & infused slowly over 6 to 8 hours
under supervisionunder supervision
 •• If required amount greater than 50If required amount greater than 50
mL given on two consecutive daysmL given on two consecutive days
I.V TherapyI.V Therapy
1- Systemic reaction:1- Systemic reaction:
 severe form : anaphylactoid reactionsevere form : anaphylactoid reaction
severe chest painsevere chest pain
 respiratory distressrespiratory distress
 circulatory collapsecirculatory collapse
2- local: skin coloration2- local: skin coloration
Adverse effects OFAdverse effects OF
IntravenousIntravenous
Acute iron intoxicationAcute iron intoxication
 Accidental ingestion of large doses of iron:Accidental ingestion of large doses of iron:
mortality rate 50%.mortality rate 50%.
 Early symptomsEarly symptoms :: Vomiting, diarrhea,Vomiting, diarrhea,
dehydration, corrosive iron ondehydration, corrosive iron on
stomach,intestines.stomach,intestines.
 LaterLater :: Severe irreversible CV collapse, shock,Severe irreversible CV collapse, shock,
coma.coma.
 markedmarked ↑↑in plasma iron.in plasma iron.
 1. Stomach wash with 1% NaHCO3 to render it insoluble and1. Stomach wash with 1% NaHCO3 to render it insoluble and
remove undissolved iron tabletsremove undissolved iron tablets
 2. IV Desferrioxamine 5 to 10 g in 100 mL isotonic saline or2. IV Desferrioxamine 5 to 10 g in 100 mL isotonic saline or
calcium sodium edetate 35 to 40 mg/Kg to retard the absorptioncalcium sodium edetate 35 to 40 mg/Kg to retard the absorption
from GITfrom GIT
 3. Early replacement of fluids and electrolytes, correction of3. Early replacement of fluids and electrolytes, correction of
metabolic acidosis and hypotension by vasopressorsmetabolic acidosis and hypotension by vasopressors
 4 Diazepam and other anticonvulsa-nts if epileptic4 Diazepam and other anticonvulsa-nts if epileptic
Treatment of Acute iron poisoningTreatment of Acute iron poisoning
 •• Potent specific chelator of iron binds ferric iron to formPotent specific chelator of iron binds ferric iron to form
ferrioxamine a stable water soluble chelateferrioxamine a stable water soluble chelate
 •• Ferrioxamine is excreted 2/3 in urine and 1/3 in bile colorsFerrioxamine is excreted 2/3 in urine and 1/3 in bile colors
urine reddish brownurine reddish brown
 •• Removes iron from hemosiderin except that in bone marrowRemoves iron from hemosiderin except that in bone marrow
 •• Well tolerated rapid I.V may causeWell tolerated rapid I.V may cause
hypotension, anaphylactic reactions andhypotension, anaphylactic reactions and
tachycardiatachycardia
 •• Allergic reactions and cataract known with chronicAllergic reactions and cataract known with chronic
administrationadministration
 •• Contraindicated in renal disease anuriaContraindicated in renal disease anuria
Desferrioxamine MesylateDesferrioxamine Mesylate
ANEMIA IN PEDIATRICS 2019
MEGALOBLASTICMEGALOBLASTIC
ANEMIASANEMIAS
 Megaloblasts in B.MMegaloblasts in B.M
 ↑↑ MCV,MCV,
 Hypersegmented neutrophils in peripheralHypersegmented neutrophils in peripheral
blood.blood.
Causes:Causes:
 Deficiency of :Deficiency of :
folic acid (megaloblastic anemia of infancy)folic acid (megaloblastic anemia of infancy)
vit.B12 (juvenile pernicious anemia).vit.B12 (juvenile pernicious anemia).
Megaloblastic anemia ofMegaloblastic anemia of
infancyinfancy
Folic acid :Folic acid :
 Normal daily requirements :Normal daily requirements : 30 - 6030 - 60 µµgg
per dayper day (10 times that of adult).(10 times that of adult).
 Folic deficiency in pregnant :Folic deficiency in pregnant :
Fetal neural tube defectsFetal neural tube defects
Preterm labour (2 folds)Preterm labour (2 folds)
LBWLBW
So folicSo folic should beshould be supplemented to pregnantsupplemented to pregnant
mothermother
Etiology of folic acidEtiology of folic acid
deficiencydeficiency
1- Inadequate intake of folic acid:1- Inadequate intake of folic acid:
 Feeding on goatFeeding on goat’’s milk (very poor in folic acid).s milk (very poor in folic acid).
 Feeding on heat-sterilized cowFeeding on heat-sterilized cow’’s milk <50% folic acid.s milk <50% folic acid.
2- Relative deficiency :2- Relative deficiency :
 Rapid growth : prematures.Rapid growth : prematures.
 Chronic hemolytic anemias, leukemias, lymphomas.Chronic hemolytic anemias, leukemias, lymphomas.
3- Defective absorption:3- Defective absorption:
 Chronic diarrhea.Chronic diarrhea.
 Prolonged antibiotics , antiepileptics (phenytoin, phenobarb.).Prolonged antibiotics , antiepileptics (phenytoin, phenobarb.).
 Malabsorption syndromes, congenital folate malabsorptionMalabsorption syndromes, congenital folate malabsorption
syndrome.syndrome.
 Folic antagonists: Co-trimoxazole, methotrexate,Folic antagonists: Co-trimoxazole, methotrexate,
pyrimethamine .pyrimethamine .
 Ascorbic acid deficiency .Ascorbic acid deficiency .
Laboratory findingsLaboratory findings
1- Peripheral blood1- Peripheral blood ::
 ↓↓ Hemoglobin (< 6 g/dl)., RBCs count.Hemoglobin (< 6 g/dl)., RBCs count.
 ↑↑ MCV to 100 fl (macrocytosis).,MCV to 100 fl (macrocytosis)., ↑↑ RDWRDW
 ↓↓ reticulocytic count.reticulocytic count.
 Neutropenia + hypersegmented nuclei ofNeutropenia + hypersegmented nuclei of
mature polymorphs.mature polymorphs.
 Mild thrombocytopenia.Mild thrombocytopenia.
 Serum & RBC folateSerum & RBC folate
2- Bone marrow :2- Bone marrow :
Hypercellular with predominant megaloblasts.Hypercellular with predominant megaloblasts.
TreatmentTreatment
 Folic acid, 2-5 mg/day P/O or inj. 3-4Folic acid, 2-5 mg/day P/O or inj. 3-4
wks.wks.
 Ascorbic acid if scurvy.Ascorbic acid if scurvy.
 Packed RBCs transfusion:Packed RBCs transfusion: ONLYONLY inin
severe cases.severe cases.
 Folinic acid in defects d.t methotrexateFolinic acid in defects d.t methotrexate
A 6 months infant has had intermittentA 6 months infant has had intermittent
diarrhoea for 1 month, after multiplediarrhoea for 1 month, after multiple
formula changes, he was receivingformula changes, he was receiving
goat milk. At 12 months of age hegoat milk. At 12 months of age he
presented with pallor, decreasedpresented with pallor, decreased
activity. Blood film was macrocytic.activity. Blood film was macrocytic.
Most likely diagnosis isMost likely diagnosis is ::
 ThalassemiaThalassemia
 GiardiasisGiardiasis
 IDAIDA
 Folate deficiencyFolate deficiency
 G6PD deficiencyG6PD deficiency folicfolic
A 18 month old girl likes to eat dirt andA 18 month old girl likes to eat dirt and
ice and her diet is cow milk with littleice and her diet is cow milk with little
amount of solid foods. On exam, sheamount of solid foods. On exam, she
was found to be pale with nowas found to be pale with no
hepatosplenomegaly.hepatosplenomegaly.
diagnosisdiagnosis
 Iron deficiency anemiaIron deficiency anemia
 Megaloblastic anemiaMegaloblastic anemia
 Acute hemolytic anemiaAcute hemolytic anemia
 Chronic hemolytic anemiaChronic hemolytic anemia
Concerning the previous girl, if Hb andConcerning the previous girl, if Hb and
Hct returned to normal, when to stopHct returned to normal, when to stop
iron therapy?iron therapy?
 Stop it as soon Hb becomes normalStop it as soon Hb becomes normal
 Continue for 1-2 weeksContinue for 1-2 weeks
 Continue for 4-8 weeksContinue for 4-8 weeks
 Continue for 4-6 weeksContinue for 4-6 weeks
 4-84-8
Thank You

More Related Content

PPTX
Anaemia in children
PPTX
Anemia in child
PPTX
Anemia in children
PPTX
ANEMIA IN CHILDREN.pptx
PPT
Approach to the child with anemia
PPTX
Approach to Iron Deficiency Anemia in Children
PPTX
Approach to anemia in children
PDF
Anemia in children 2021
Anaemia in children
Anemia in child
Anemia in children
ANEMIA IN CHILDREN.pptx
Approach to the child with anemia
Approach to Iron Deficiency Anemia in Children
Approach to anemia in children
Anemia in children 2021

What's hot (20)

PDF
Hemolytic anemia in children 2021
PPTX
Acute renal failure in children
PPTX
Anemia of prematurity
PPTX
Prematurity Pediatrics
PPTX
Pneumonia Pediatric
PPTX
URINARY TRACT INFECTION IN CHILDREN
PPT
NEPHRITIC SYNDROME / APSGN IN CHILDREN
PPTX
Acute kidney injury in pediatrics
PPTX
Pediatric thrombocytopenia
PPT
Hemophilia (a) - Pediatrics
PPTX
Acute kidney injury in children 2018
PDF
Aplastic anemia in children 2021
PPT
Hypoxic ischemic encephalopathy: Lecture on HIE
PPTX
diabetes mellitus in children
PPTX
Leukemias in children
PDF
Celiac disease in children 2021
PPTX
Leukemia in Children
PPTX
Thyroid disorders in children
PPTX
PPTX
Malnutrition in children
Hemolytic anemia in children 2021
Acute renal failure in children
Anemia of prematurity
Prematurity Pediatrics
Pneumonia Pediatric
URINARY TRACT INFECTION IN CHILDREN
NEPHRITIC SYNDROME / APSGN IN CHILDREN
Acute kidney injury in pediatrics
Pediatric thrombocytopenia
Hemophilia (a) - Pediatrics
Acute kidney injury in children 2018
Aplastic anemia in children 2021
Hypoxic ischemic encephalopathy: Lecture on HIE
diabetes mellitus in children
Leukemias in children
Celiac disease in children 2021
Leukemia in Children
Thyroid disorders in children
Malnutrition in children
Ad

Similar to ANEMIA IN PEDIATRICS 2019 (20)

PPT
Diagnosis of anemia part 1
PPT
Hematology lecture presentation of Pathology.ppt
PPT
Anaemia _ IDA & Megaloblastic anaemia Lect 1.ppt
PPT
Iron Deficiency Anemia/Dr. Youssef Quda
PPTX
Haematinics & Plasma expanders Final.pptx
PPTX
Anaemia in pregnancy
PPT
Anemia in Pregnancy
PPTX
IRON DEFICIENCY ANEMIA
PPT
Anemia in pregnancy
PPTX
Anemia types of anemia and causes of anemia
PPTX
Iron deficiency anaemia
PPTX
Iron deficiency anaemia
PPT
Anemia with pregnancy
PPTX
Biochemical Assessment PowerPoint
PDF
Mineral metabolism.pdf
PPTX
Anaemia
PPT
外文讲义5
PDF
Biochemical Assessment of Nutritional Status.pdf
PPTX
Anemia classification clinical feature treatment
PPTX
anaemiainpregnancy-130126071738-phpapp01-150807154305-lva1-app6891.pptx
Diagnosis of anemia part 1
Hematology lecture presentation of Pathology.ppt
Anaemia _ IDA & Megaloblastic anaemia Lect 1.ppt
Iron Deficiency Anemia/Dr. Youssef Quda
Haematinics & Plasma expanders Final.pptx
Anaemia in pregnancy
Anemia in Pregnancy
IRON DEFICIENCY ANEMIA
Anemia in pregnancy
Anemia types of anemia and causes of anemia
Iron deficiency anaemia
Iron deficiency anaemia
Anemia with pregnancy
Biochemical Assessment PowerPoint
Mineral metabolism.pdf
Anaemia
外文讲义5
Biochemical Assessment of Nutritional Status.pdf
Anemia classification clinical feature treatment
anaemiainpregnancy-130126071738-phpapp01-150807154305-lva1-app6891.pptx
Ad

More from Hussein Abdeldayem (20)

PPTX
Pediatric oral abnormalities
PPT
Hemophilia in dental clinic
PPTX
infective endocarditis in children for PEDO 2019
PPTX
Nocturnal enuresis 2019
PPTX
Tips for treatment of childhood epilepsy
PPT
PEDO CARE FOR: SEIZURES AND EPILEPSY, MR, CP AND ADHD. General care and clini...
PPTX
PEDO: New guidelines for prophylaxis against infective endocarditis
PPT
Pedo autism
PPT
Down syndrome for PEDO
PPTX
Omega in pediatric neurology
PPTX
Pediatric neurology examination make it easy
PPTX
NON PHARMACOLOGICAL TREATMENT PROTOCOL OF ADHD
PPT
Brain plasticity FOR PEDIATRIC SURGERY
PPT
practical points for G6PD Deficiency , Favism
PPT
Iron deficiency anemia
PPT
Seizures and epilepsy FOR clinical pharmacy student
PPT
formula milk formula for clinical pharmacy students
PPT
ADHD FOR CLINICAL PHARMACY STUDENT
PPT
Autism treatment FOR CLINICAL pharmacy
PPT
Prevention and vaccine pediatrics for clinical pharmacy
Pediatric oral abnormalities
Hemophilia in dental clinic
infective endocarditis in children for PEDO 2019
Nocturnal enuresis 2019
Tips for treatment of childhood epilepsy
PEDO CARE FOR: SEIZURES AND EPILEPSY, MR, CP AND ADHD. General care and clini...
PEDO: New guidelines for prophylaxis against infective endocarditis
Pedo autism
Down syndrome for PEDO
Omega in pediatric neurology
Pediatric neurology examination make it easy
NON PHARMACOLOGICAL TREATMENT PROTOCOL OF ADHD
Brain plasticity FOR PEDIATRIC SURGERY
practical points for G6PD Deficiency , Favism
Iron deficiency anemia
Seizures and epilepsy FOR clinical pharmacy student
formula milk formula for clinical pharmacy students
ADHD FOR CLINICAL PHARMACY STUDENT
Autism treatment FOR CLINICAL pharmacy
Prevention and vaccine pediatrics for clinical pharmacy

Recently uploaded (20)

PPT
Management of Acute Kidney Injury at LAUTECH
PDF
Handout_ NURS 220 Topic 10-Abnormal Pregnancy.pdf
DOCX
NEET PG 2025 | Pharmacology Recall: 20 High-Yield Questions Simplified
PDF
Khadir.pdf Acacia catechu drug Ayurvedic medicine
PDF
Deadly Stampede at Yaounde’s Olembe Stadium Forensic.pdf
PPTX
neonatal infection(7392992y282939y5.pptx
PDF
Human Health And Disease hggyutgghg .pdf
PPT
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer
PDF
Medical Evidence in the Criminal Justice Delivery System in.pdf
PPT
Breast Cancer management for medicsl student.ppt
PPTX
Acid Base Disorders educational power point.pptx
PDF
Therapeutic Potential of Citrus Flavonoids in Metabolic Inflammation and Ins...
PPT
OPIOID ANALGESICS AND THEIR IMPLICATIONS
PPTX
1 General Principles of Radiotherapy.pptx
PDF
NEET PG 2025 | 200 High-Yield Recall Topics Across All Subjects
DOC
Adobe Premiere Pro CC Crack With Serial Key Full Free Download 2025
PDF
Intl J Gynecology Obste - 2021 - Melamed - FIGO International Federation o...
PPT
Obstructive sleep apnea in orthodontics treatment
PPTX
surgery guide for USMLE step 2-part 1.pptx
DOCX
RUHS II MBBS Microbiology Paper-II with Answer Key | 6th August 2025 (New Sch...
Management of Acute Kidney Injury at LAUTECH
Handout_ NURS 220 Topic 10-Abnormal Pregnancy.pdf
NEET PG 2025 | Pharmacology Recall: 20 High-Yield Questions Simplified
Khadir.pdf Acacia catechu drug Ayurvedic medicine
Deadly Stampede at Yaounde’s Olembe Stadium Forensic.pdf
neonatal infection(7392992y282939y5.pptx
Human Health And Disease hggyutgghg .pdf
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer
Medical Evidence in the Criminal Justice Delivery System in.pdf
Breast Cancer management for medicsl student.ppt
Acid Base Disorders educational power point.pptx
Therapeutic Potential of Citrus Flavonoids in Metabolic Inflammation and Ins...
OPIOID ANALGESICS AND THEIR IMPLICATIONS
1 General Principles of Radiotherapy.pptx
NEET PG 2025 | 200 High-Yield Recall Topics Across All Subjects
Adobe Premiere Pro CC Crack With Serial Key Full Free Download 2025
Intl J Gynecology Obste - 2021 - Melamed - FIGO International Federation o...
Obstructive sleep apnea in orthodontics treatment
surgery guide for USMLE step 2-part 1.pptx
RUHS II MBBS Microbiology Paper-II with Answer Key | 6th August 2025 (New Sch...

ANEMIA IN PEDIATRICS 2019

  • 1. 11--ANEMIA INANEMIA IN PEDIATRICSPEDIATRICS for clinical pharmacyfor clinical pharmacy Prof Dr Hussein AbdeldayemProf Dr Hussein Abdeldayem Professor of Pediatrics,Professor of Pediatrics, Alex UniversityAlex University
  • 2. FACTORS FORFACTORS FOR ERYTHROPOIESISERYTHROPOIESIS  Bone MarrowBone Marrow  ERYTHROPOIETIN (90%kidney,ERYTHROPOIETIN (90%kidney, 10%liver)10%liver)  Nutritional factors:Nutritional factors: 1- protein: AA1- protein: AA 2- iron2- iron 3- B12, folic acid3- B12, folic acid 4- copper, cobalt4- copper, cobalt 5- ascorbic acid5- ascorbic acid
  • 3. Regulation ofRegulation of ErythropoiesisErythropoiesis  While the kidney produces most of theWhile the kidney produces most of the erythropoietin, the liver and othererythropoietin, the liver and other tissues also produce some.tissues also produce some.  In fetal life, the liver produced all of theIn fetal life, the liver produced all of the erythropoietinerythropoietin –– as the final kidneyas the final kidney –– the metanephros - had not yetthe metanephros - had not yet completed development.completed development.
  • 4. Regulation ofRegulation of ErythropoiesisErythropoiesis  How many are produced:How many are produced: – 25 billion /24 hours.25 billion /24 hours. – The entering cells are reticulocytes whichThe entering cells are reticulocytes which should be 1% of the total population ofshould be 1% of the total population of circulating erythrocytes.circulating erythrocytes. – Erythrocytes last 120 days and areErythrocytes last 120 days and are destroyed by the spleen.destroyed by the spleen. – Red cell production should equal red cellRed cell production should equal red cell destruction.destruction.
  • 5. Uses of erythropoietinUses of erythropoietin epoetin alfaepoetin alfa Indication:  Anemia of chronic renal failure.  Cancer and AIDS chemotherapy  Transplant patients  Chronic inflammatrory illness as SLE  Prematurity .  Anemia in surgical or extracorporeal proceduresAnemia in surgical or extracorporeal procedures because the pumps may have destroyed many redbecause the pumps may have destroyed many red blood cells.blood cells.
  • 6. Uses of epoetin alfaUses of epoetin alfa  Recommended starting dose is 80 – 120 U/kg - sc three times a week. Average maintenance dose - 75 U/kg, three times a week in most patients.  The most common side effect - aggravation of hypertension
  • 10. Hematologic Value Hb (g/dl) Ht % RBCs Nucleated RBCs % Reticulocytes % Cord 17 55 5.3 6 5 3 m 11.5 35 4.3 0 1 6m-6y 12.5 37 4.7 0 1 7-12 y 13 39 5 0 1 Normal RBC
  • 11. What is AnemiaWhat is Anemia??  Anemia is a decrease in HbAnemia is a decrease in Hb concentration or the number of redconcentration or the number of red blood cells (RBC) as measuredblood cells (RBC) as measured – 1. gm per cu mm or1. gm per cu mm or – 2. by volume of packed RBC per 100 ml2. by volume of packed RBC per 100 ml of blood. This is clinically obtained byof blood. This is clinically obtained by doing a hematocrit (HCT)doing a hematocrit (HCT) Below average of normal values for ageBelow average of normal values for age and sexand sex
  • 12. ANEMIAS CLASSIFICATION OF ANEMIAS 1. Anemia from inadequate erythropoiesis. 2. Anemia of blood loss (post-hemorrhagic). 3. Anemia due to ↑ destruction (hemolytic).
  • 13. ANEMIAS Diagnosis: Type, Severity, Etiology CLINICAL EVALUATION: 1. Common manifestations: Pallor, exercise intolerance, dyspnoea, palpitations, headache, lack of conc., irritability, syncope, hemic murmurs. 2. Less commonly: anorexia, nausea, flatulence, constipation, mild proteinuria, fever 3. Severe cases: ↑ C.O, CHF
  • 16. Laboratory Investigations 1. CBC * Hct, Hb * RBCs count, WBCs, Platelets * Reticulocytes •Cell morphology •* Blood Indices: MCV MCH MCHC RDW=11.5-14.5%
  • 17. Primary LaboratoryPrimary Laboratory InvestigationInvestigation  The increased reticulocyte count isThe increased reticulocyte count is usually accompanied by peripheralusually accompanied by peripheral smear RBC polychromasiasmear RBC polychromasia
  • 18. Reticulocyte CountReticulocyte Count  Is required in the evaluationIs required in the evaluation of all patients with anemia asof all patients with anemia as it is a simple measure ofit is a simple measure of productionproduction  Young RBC that still containsYoung RBC that still contains a small amount of RNAa small amount of RNA  Normally take 1 day forNormally take 1 day for reticulocyte to mature.reticulocyte to mature.  1/1201/120thth of RBC normallyof RBC normally
  • 19. Classification according to MCV Microcytic Iron deficiency Thalassemia Lead poisoning Chronic disease Normocytic ↓ Production Macrocytic Vit. B12 Folic acid
  • 20. 2. Biochemical Investigations A. Iron status Serum iron (N 60-150 µg/dl) TIBC (N 100-400 µg/dl) Serum ferritin (N 10-150 ng/dl) B. Megaloblastic anemia Serum vit. B12, folate Laboratory Investigations
  • 21. Commonest Causes of Anemia Nutritional Deficiency : Iron Deficiency Acute Hemolytic: G6PDD Chronic Hemolytic: β-Thalassemia
  • 24. ANEMIAS DUE TO DEFICIENCYANEMIAS DUE TO DEFICIENCY OF SPECIFIC NUTRIENTSOF SPECIFIC NUTRIENTS IRON DEFICIENCY ANEMIAIRON DEFICIENCY ANEMIA  Most commonMost common nutritional deficiency innutritional deficiency in children and is worldwide.children and is worldwide.  Highest :Highest : ●● 6 - 246 - 24 monthsmonths ●● artificially fed infants.artificially fed infants. ●● low socioeconomic status.low socioeconomic status.
  • 25. Iron-deficiency anemia remains the mostIron-deficiency anemia remains the most common nutritional problem from a globalcommon nutritional problem from a global perspective, it is estimated that roughly 2-5%perspective, it is estimated that roughly 2-5% of the world population are anaemic.of the world population are anaemic. Prevalence of Iron Deficiency AnemiaPrevalence of Iron Deficiency Anemia
  • 26. Normal Daily IronNormal Daily Iron RequirementsRequirements  FT baby: with store enough for 4 moFT baby: with store enough for 4 mo  PMT baby: with store enough for 2 moPMT baby: with store enough for 2 mo  1mg/kg/day elemental iron for infants and1mg/kg/day elemental iron for infants and children (max 15 mg/day)children (max 15 mg/day)  2 mg/kg/day elemental iron for low birth2 mg/kg/day elemental iron for low birth weight and newborns with very low initial Hbweight and newborns with very low initial Hb valuesvalues  6 mg/kg/day elemental iron is needed for tt6 mg/kg/day elemental iron is needed for tt for 3 mofor 3 mo
  • 27. Dietary ironDietary iron  I:Heme iron compoundsI:Heme iron compounds (hemoglobin and(hemoglobin and myoglobin) :myoglobin) : foods of animal origin:foods of animal origin: 1.5 - 6 mg1.5 - 6 mg iron /100 giron /100 g meat, liver, poultry, fish, etc.meat, liver, poultry, fish, etc. Easily digested and readily absorbed.Easily digested and readily absorbed. Absorption is not affected by diet.Absorption is not affected by diet.  II:Non-heme ironII:Non-heme iron ( ferric iron salts ) :( ferric iron salts ) : egg yolk, green vegetables, whole grains, legumes,egg yolk, green vegetables, whole grains, legumes, nutsnuts (( ++ 1.5 mg/100 g)1.5 mg/100 g). ferric. ferric →→ ferrous beforeferrous before absorption.absorption. Absorption (50% : breast milk , 10% of cowAbsorption (50% : breast milk , 10% of cow ’’s milks milk iron .iron . AbsorptionAbsorption ↑↑ : Vitamin C, sugar, amino acids (meat,: Vitamin C, sugar, amino acids (meat, poultry, fish) & HCl.poultry, fish) & HCl. AbsorptionAbsorption ↓↓ : Fibers (bran), tannate (tea),: Fibers (bran), tannate (tea),
  • 28. Iron is used inIron is used in::  Hemoglobin: transfer O2 to tissuesHemoglobin: transfer O2 to tissues  Heme enzymes, e.g., cytochromes, catalase,Heme enzymes, e.g., cytochromes, catalase, peroxidaseperoxidase  Myoglobin:transfer O2 to muscle cellsMyoglobin:transfer O2 to muscle cells  Metalloflavoprotein enzymes such as xanthineMetalloflavoprotein enzymes such as xanthine oxidaseoxidase  The mitochondrial enzyme alpha-The mitochondrial enzyme alpha- glycerophosphate oxidase and otherglycerophosphate oxidase and other mitochondrial enzymes.mitochondrial enzymes.  Other enzymes and processesOther enzymes and processes
  • 29.  Most commonMost common nutritional deficiency innutritional deficiency in children and is worldwide.children and is worldwide.  More common at:More common at: ●● 6 - 246 - 24 monthsmonths ●● artificially fed infants.artificially fed infants. ●● low socioeconomic statuslow socioeconomic status IRON DEFICIENCYIRON DEFICIENCY ANEMIAANEMIA
  • 30. STAGESSTAGES Iron stores S.IronIron stores S.Iron AnemiaAnemia (s. ferritin)(s. ferritin)  Stage of IRONStage of IRON Low Normal NoneLow Normal None DEPLETIONDEPLETION  Stage of IRONStage of IRON Absent Low NoneAbsent Low None DEFICIENCYDEFICIENCY  Stage of IRONStage of IRON Absent Low PresentAbsent Low Present DEF. ANEMIADEF. ANEMIA
  • 31.  ↓↓ iron stores.iron stores.  ↓↓ iron‑storage protein (ferritin)iron‑storage protein (ferritin)  ↓↓ serum ironserum iron  ↑↑iron binding capacity TIBC.iron binding capacity TIBC.  Anemia: hypochromia,microcytosis.Anemia: hypochromia,microcytosis.  ↓↓ activity of iron‑containing intraactivity of iron‑containing intra ­­ cellular enzymes (e.g. CNS -MAO).cellular enzymes (e.g. CNS -MAO). PathogenesisPathogenesis
  • 32. Clinical manifestationsClinical manifestations - Particular CP due to effect of iron def. on- Particular CP due to effect of iron def. on systems:systems:  GIT:GIT: Anorexia, glossitis, Pica (ingestion of wallAnorexia, glossitis, Pica (ingestion of wall plaster, clay), Geophagia (earth), Pagophagiaplaster, clay), Geophagia (earth), Pagophagia (ice,(ice,  CNS:CNS: Short attention span, irritability, breathShort attention span, irritability, breath holding,holding, ↓↓ alertness, ↓ learning ability and schoolalertness, ↓ learning ability and school performance.performance.
  • 33.  IRON replacement TREATMENT (oral,IRON replacement TREATMENT (oral, IM, IV)IM, IV)  TREAT THE CAUSETREAT THE CAUSE TREATMENTTREATMENT
  • 34. TreatmentTreatment Oral Iron saltsOral Iron salts:: 6 mg/kg/day elemental for 3 mo6 mg/kg/day elemental for 3 mo  Ferrous sulfate drops for infants ( 20%Ferrous sulfate drops for infants ( 20% elemental iron).elemental iron).  Ferrous gluconate drops ( 12 % elementalFerrous gluconate drops ( 12 % elemental iron).iron).  ferrous fumarate (30% elemental iron) tabletsferrous fumarate (30% elemental iron) tablets or syrup for older children.or syrup for older children.  Iron better between meals. fibers (e.g. wholeIron better between meals. fibers (e.g. whole bread and cereals), tannate (like tea),bread and cereals), tannate (like tea), phosphates (in bread, cow's milk and eggphosphates (in bread, cow's milk and egg yolk) and phytic acid ↓ absorption of iron.yolk) and phytic acid ↓ absorption of iron.  absorption ↑ by vitamin C (e.g. citrous fruits),absorption ↑ by vitamin C (e.g. citrous fruits), sugar and amino acids (meat, poultry, fish).sugar and amino acids (meat, poultry, fish).
  • 35. TreatmentTreatment Parenteral iron therapyParenteral iron therapy :: Iron dextranIron dextran mixture (mixture (ImferonImferon))®® 50 mg elemental iron / ml50 mg elemental iron / ml only in intolerance or malabsorptiononly in intolerance or malabsorption Packed RBC transfusionPacked RBC transfusion :: SeverelySeverely anemic children with Hb < 4 g/dlanemic children with Hb < 4 g/dl Treatment of etiologyTreatment of etiology correct diet , ttcorrect diet , tt parasiteparasite
  • 36.  These preparation are mostlyThese preparation are mostly available as ferrous(Fe+2) and someavailable as ferrous(Fe+2) and some in ferric(Fe+3)formin ferric(Fe+3)form   Ferrous salt are better absorbedFerrous salt are better absorbed than ferric saltsthan ferric salts ORAL IRON THERAPYORAL IRON THERAPY
  • 37.  Iron is poorly absorbed in the form ofIron is poorly absorbed in the form of carbonate, citrate and pyrophosphate,carbonate, citrate and pyrophosphate, colloidal iron and iron carbohydratecolloidal iron and iron carbohydrate complexcomplex  FORMS :FORMS : Tablets, capsulesTablets, capsules Sugar coated & uncoated tablets •Sugar coated & uncoated tablets • Slow release tabsSlow release tabs chewable tabs •chewable tabs • Drops &syrups—used by children'sDrops &syrups—used by children's
  • 38.  1. Ferrous sulphate: 20 – 32% iron1. Ferrous sulphate: 20 – 32% iron  2. Ferrous fumarate: 33% elemental2. Ferrous fumarate: 33% elemental ironiron  3. Ferrous gluconate : 12% elemental3. Ferrous gluconate : 12% elemental ironiron  4. Colloidal ferric hydroxide:50%4. Colloidal ferric hydroxide:50% elemental iron •elemental iron •  Other oral preparations are ferrousOther oral preparations are ferrous choline citrate , ferric ammoniumcholine citrate , ferric ammonium citrate , iron calcium complex, ironcitrate , iron calcium complex, iron hydroxy polymatose.hydroxy polymatose. FERRIC HYDROCHLORIDE POLYMALTOSE
  • 39.  It is rapidly absorbed, with a high rate of ironIt is rapidly absorbed, with a high rate of iron utilization and produces an effective increase inutilization and produces an effective increase in Haemoglobin. Due to its favourable nonionicHaemoglobin. Due to its favourable nonionic nature it has the following properties unlikenature it has the following properties unlike ionised iron salt preparations: · Ferose does notionised iron salt preparations: · Ferose does not give rise to irritation of the intestinal mucosa andgive rise to irritation of the intestinal mucosa and does not stain the teeth. · Ferose has palatable,does not stain the teeth. · Ferose has palatable, non metallic taste (Ferose chewable tablets havenon metallic taste (Ferose chewable tablets have chocolate flavour and are acceptable even by thechocolate flavour and are acceptable even by the most resistant patients of all ages). · Ferose hasmost resistant patients of all ages). · Ferose has excellent tolerance.excellent tolerance. Ferrous form of oral ironFerrous form of oral iron FEROSEFEROSE
  • 40.  •• Important points to remember ;ElementalImportant points to remember ;Elemental iron content and not quantity of ironiron content and not quantity of iron compound per unit dose to be consideredcompound per unit dose to be considered  Sustained released preparations expensiveSustained released preparations expensive and irrationaland irrational  Liquid formulations: should be put on backLiquid formulations: should be put on back of tongue and swallowedof tongue and swallowed
  • 41. Iron saltsIron salts  Ferrous sulfateFerrous sulfate ––least expensiveleast expensive –– treatment oftreatment of choicechoice  Ferrous salts (sulfate, fumarate, gluconate,Ferrous salts (sulfate, fumarate, gluconate, succinate) are absorbed about three times assuccinate) are absorbed about three times as well as ferric salts.well as ferric salts.  Vitamin C increases absorption - AscorbicVitamin C increases absorption - Ascorbic acid, 200 mg or more, increases absorption byacid, 200 mg or more, increases absorption by at least 30% (with increased incidence of sideat least 30% (with increased incidence of side effects too)effects too)  Carbonyl iron: microspheres of pure ironCarbonyl iron: microspheres of pure iron –– lessless gastrointestinal toxicity than iron saltsgastrointestinal toxicity than iron salts
  • 42.  •• Constipation (BLACK) is commonConstipation (BLACK) is common than diarrheathan diarrhea  •• Epigastric painEpigastric pain  •• VomitingVomiting  •• Heart burnHeart burn  •• Metallic tasteMetallic taste  •• NauseaNausea  •• Staining of teeth.Staining of teeth. Adverse reactions to oralAdverse reactions to oral ironiron
  • 43.  •• Oral iron is not toleratedOral iron is not tolerated  •• Failure to absorb oral ironFailure to absorb oral iron  •• Non compliance to oral ironNon compliance to oral iron  •• In presence of severe deficiency withIn presence of severe deficiency with chronic bleedingchronic bleeding Indications of parenteralIndications of parenteral therapytherapy
  • 44.  •• Parenteral iron therapy needsParenteral iron therapy needs calculation of total iron requirement ofcalculation of total iron requirement of the patient –the patient – Iron requirement (mg) = 4.4 X Body wtIron requirement (mg) = 4.4 X Body wt (Kg) X Hb deficit g/dL(Kg) X Hb deficit g/dL Calculation for parenteralCalculation for parenteral ironiron
  • 45.  1. Iron dextran (Imferon): I.V/ I.M1. Iron dextran (Imferon): I.V/ I.M  2. Iron sorbitol citric acid complex:2. Iron sorbitol citric acid complex: Only I.M 3. Iron carbohydrate complexOnly I.M 3. Iron carbohydrate complex : I.M: I.M  4. Sodium ferric gluconate: Recently4. Sodium ferric gluconate: Recently approved preparation for I.V use hasapproved preparation for I.V use has much lower risk of anaphylacticmuch lower risk of anaphylactic reaction than iron dextranreaction than iron dextran Parenteral ironParenteral iron preparationspreparations
  • 46.  •• Iron dextran and iron sorbitol bothIron dextran and iron sorbitol both contain 50 mg/mL recommended dosecontain 50 mg/mL recommended dose is 100 mg daily 2 mL on alternate daysis 100 mg daily 2 mL on alternate days until total required dose isuntil total required dose is administered or maximum 2 g .administered or maximum 2 g .  To prevent staining to skin given deepTo prevent staining to skin given deep I.M in buttock using z track techniqueI.M in buttock using z track technique I.M therapyI.M therapy Elemental iron 100 mg (As Ferric hydroxide polymaltose complex)
  • 47.  •• Intramuscular: – Local pain at site ,Intramuscular: – Local pain at site , pigmentation of skin , sterile abcesspigmentation of skin , sterile abcess  –– Systemic: headache, fever,Systemic: headache, fever, arthralgia, backache, tachycardia,arthralgia, backache, tachycardia, flushing hemolysis and collapse theseflushing hemolysis and collapse these effects are probably due to excessiveeffects are probably due to excessive amount of free iron in plasmaamount of free iron in plasma  –– Iron sorbitol may causeIron sorbitol may cause disorientation and temporary loss ofdisorientation and temporary loss of taste, urine turns black on standingtaste, urine turns black on standing Adverse effectsAdverse effects
  • 48.  •• Iron dextran after test dose 0.5 mLIron dextran after test dose 0.5 mL iron dextran injected I.V over 5 to 10iron dextran injected I.V over 5 to 10 minmin  •• Total dose required diluted in 500 mLTotal dose required diluted in 500 mL NS & infused slowly over 6 to 8 hoursNS & infused slowly over 6 to 8 hours under supervisionunder supervision  •• If required amount greater than 50If required amount greater than 50 mL given on two consecutive daysmL given on two consecutive days I.V TherapyI.V Therapy
  • 49. 1- Systemic reaction:1- Systemic reaction:  severe form : anaphylactoid reactionsevere form : anaphylactoid reaction severe chest painsevere chest pain  respiratory distressrespiratory distress  circulatory collapsecirculatory collapse 2- local: skin coloration2- local: skin coloration Adverse effects OFAdverse effects OF IntravenousIntravenous
  • 50. Acute iron intoxicationAcute iron intoxication  Accidental ingestion of large doses of iron:Accidental ingestion of large doses of iron: mortality rate 50%.mortality rate 50%.  Early symptomsEarly symptoms :: Vomiting, diarrhea,Vomiting, diarrhea, dehydration, corrosive iron ondehydration, corrosive iron on stomach,intestines.stomach,intestines.  LaterLater :: Severe irreversible CV collapse, shock,Severe irreversible CV collapse, shock, coma.coma.  markedmarked ↑↑in plasma iron.in plasma iron.
  • 51.  1. Stomach wash with 1% NaHCO3 to render it insoluble and1. Stomach wash with 1% NaHCO3 to render it insoluble and remove undissolved iron tabletsremove undissolved iron tablets  2. IV Desferrioxamine 5 to 10 g in 100 mL isotonic saline or2. IV Desferrioxamine 5 to 10 g in 100 mL isotonic saline or calcium sodium edetate 35 to 40 mg/Kg to retard the absorptioncalcium sodium edetate 35 to 40 mg/Kg to retard the absorption from GITfrom GIT  3. Early replacement of fluids and electrolytes, correction of3. Early replacement of fluids and electrolytes, correction of metabolic acidosis and hypotension by vasopressorsmetabolic acidosis and hypotension by vasopressors  4 Diazepam and other anticonvulsa-nts if epileptic4 Diazepam and other anticonvulsa-nts if epileptic Treatment of Acute iron poisoningTreatment of Acute iron poisoning
  • 52.  •• Potent specific chelator of iron binds ferric iron to formPotent specific chelator of iron binds ferric iron to form ferrioxamine a stable water soluble chelateferrioxamine a stable water soluble chelate  •• Ferrioxamine is excreted 2/3 in urine and 1/3 in bile colorsFerrioxamine is excreted 2/3 in urine and 1/3 in bile colors urine reddish brownurine reddish brown  •• Removes iron from hemosiderin except that in bone marrowRemoves iron from hemosiderin except that in bone marrow  •• Well tolerated rapid I.V may causeWell tolerated rapid I.V may cause hypotension, anaphylactic reactions andhypotension, anaphylactic reactions and tachycardiatachycardia  •• Allergic reactions and cataract known with chronicAllergic reactions and cataract known with chronic administrationadministration  •• Contraindicated in renal disease anuriaContraindicated in renal disease anuria Desferrioxamine MesylateDesferrioxamine Mesylate
  • 54. MEGALOBLASTICMEGALOBLASTIC ANEMIASANEMIAS  Megaloblasts in B.MMegaloblasts in B.M  ↑↑ MCV,MCV,  Hypersegmented neutrophils in peripheralHypersegmented neutrophils in peripheral blood.blood. Causes:Causes:  Deficiency of :Deficiency of : folic acid (megaloblastic anemia of infancy)folic acid (megaloblastic anemia of infancy) vit.B12 (juvenile pernicious anemia).vit.B12 (juvenile pernicious anemia).
  • 55. Megaloblastic anemia ofMegaloblastic anemia of infancyinfancy Folic acid :Folic acid :  Normal daily requirements :Normal daily requirements : 30 - 6030 - 60 µµgg per dayper day (10 times that of adult).(10 times that of adult).  Folic deficiency in pregnant :Folic deficiency in pregnant : Fetal neural tube defectsFetal neural tube defects Preterm labour (2 folds)Preterm labour (2 folds) LBWLBW So folicSo folic should beshould be supplemented to pregnantsupplemented to pregnant mothermother
  • 56. Etiology of folic acidEtiology of folic acid deficiencydeficiency 1- Inadequate intake of folic acid:1- Inadequate intake of folic acid:  Feeding on goatFeeding on goat’’s milk (very poor in folic acid).s milk (very poor in folic acid).  Feeding on heat-sterilized cowFeeding on heat-sterilized cow’’s milk <50% folic acid.s milk <50% folic acid. 2- Relative deficiency :2- Relative deficiency :  Rapid growth : prematures.Rapid growth : prematures.  Chronic hemolytic anemias, leukemias, lymphomas.Chronic hemolytic anemias, leukemias, lymphomas. 3- Defective absorption:3- Defective absorption:  Chronic diarrhea.Chronic diarrhea.  Prolonged antibiotics , antiepileptics (phenytoin, phenobarb.).Prolonged antibiotics , antiepileptics (phenytoin, phenobarb.).  Malabsorption syndromes, congenital folate malabsorptionMalabsorption syndromes, congenital folate malabsorption syndrome.syndrome.  Folic antagonists: Co-trimoxazole, methotrexate,Folic antagonists: Co-trimoxazole, methotrexate, pyrimethamine .pyrimethamine .  Ascorbic acid deficiency .Ascorbic acid deficiency .
  • 57. Laboratory findingsLaboratory findings 1- Peripheral blood1- Peripheral blood ::  ↓↓ Hemoglobin (< 6 g/dl)., RBCs count.Hemoglobin (< 6 g/dl)., RBCs count.  ↑↑ MCV to 100 fl (macrocytosis).,MCV to 100 fl (macrocytosis)., ↑↑ RDWRDW  ↓↓ reticulocytic count.reticulocytic count.  Neutropenia + hypersegmented nuclei ofNeutropenia + hypersegmented nuclei of mature polymorphs.mature polymorphs.  Mild thrombocytopenia.Mild thrombocytopenia.  Serum & RBC folateSerum & RBC folate 2- Bone marrow :2- Bone marrow : Hypercellular with predominant megaloblasts.Hypercellular with predominant megaloblasts.
  • 58. TreatmentTreatment  Folic acid, 2-5 mg/day P/O or inj. 3-4Folic acid, 2-5 mg/day P/O or inj. 3-4 wks.wks.  Ascorbic acid if scurvy.Ascorbic acid if scurvy.  Packed RBCs transfusion:Packed RBCs transfusion: ONLYONLY inin severe cases.severe cases.  Folinic acid in defects d.t methotrexateFolinic acid in defects d.t methotrexate
  • 59. A 6 months infant has had intermittentA 6 months infant has had intermittent diarrhoea for 1 month, after multiplediarrhoea for 1 month, after multiple formula changes, he was receivingformula changes, he was receiving goat milk. At 12 months of age hegoat milk. At 12 months of age he presented with pallor, decreasedpresented with pallor, decreased activity. Blood film was macrocytic.activity. Blood film was macrocytic. Most likely diagnosis isMost likely diagnosis is ::  ThalassemiaThalassemia  GiardiasisGiardiasis  IDAIDA  Folate deficiencyFolate deficiency  G6PD deficiencyG6PD deficiency folicfolic
  • 60. A 18 month old girl likes to eat dirt andA 18 month old girl likes to eat dirt and ice and her diet is cow milk with littleice and her diet is cow milk with little amount of solid foods. On exam, sheamount of solid foods. On exam, she was found to be pale with nowas found to be pale with no hepatosplenomegaly.hepatosplenomegaly. diagnosisdiagnosis  Iron deficiency anemiaIron deficiency anemia  Megaloblastic anemiaMegaloblastic anemia  Acute hemolytic anemiaAcute hemolytic anemia  Chronic hemolytic anemiaChronic hemolytic anemia
  • 61. Concerning the previous girl, if Hb andConcerning the previous girl, if Hb and Hct returned to normal, when to stopHct returned to normal, when to stop iron therapy?iron therapy?  Stop it as soon Hb becomes normalStop it as soon Hb becomes normal  Continue for 1-2 weeksContinue for 1-2 weeks  Continue for 4-8 weeksContinue for 4-8 weeks  Continue for 4-6 weeksContinue for 4-6 weeks  4-84-8